Humanigen, Inc. - Common Stock (NQ:HGEN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Humanigen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Humanigen Receives Preliminary Topline Data From NIH/NIAID Study of Lenzilumab in ACTIV-5/BET-B

July 12, 2022

From Humanigen, Inc.

Via Business Wire

Tesla, Twitter And 76 Biggest Movers From Friday ↗

July 11, 2022

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...

Via Benzinga

Coinbase, Moderna And 56 Biggest Movers From Yesterday ↗

July 07, 2022

Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time...

Via Benzinga

Why Is DoorDash Down By 8%? 38 Stocks Moving In Wednesday's Mid-Day Session ↗

July 06, 2022

Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change...

Via Benzinga

Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by C-Reactive Protein

July 06, 2022

From Humanigen, Inc.

Via Business Wire

NIH/NIAID Locks ACTIV-5/BET-B Database

June 30, 2022

From Humanigen, Inc.

Via Business Wire

Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom

June 16, 2022

From Humanigen, Inc.

Via Business Wire

Humanigen Announces Participation and Presentation at Multiple Conferences in June

June 03, 2022

From Humanigen, Inc.

Via Business Wire

Humanigen Announces Participation and Presentation at H.C. Wainwright Global Investment Conference

May 24, 2022

From Humanigen, Inc.

Via Business Wire

24 Stocks Moving in Monday's Pre-Market Session ↗

May 23, 2022

Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on Friday.

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 20, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

May 19, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for...

Via Benzinga

92 Biggest Movers From Friday ↗

May 09, 2022

Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...

Via Benzinga

Humanigen Reports First Quarter 2022 Financial Results

May 05, 2022

From Humanigen, Inc.

Via Business Wire

Humanigen Announces Participation and Presentation at Multiple Conferences in May

May 04, 2022

From Humanigen, Inc.

Via Business Wire

Humanigen Announces Peer-Reviewed Publication Demonstrating the Potential Clinical and Economic Benefits of Lenzilumab from the Perspective of the NHS

April 19, 2022

From Humanigen, Inc.

Via Business Wire

Drug makers, Scientists Working For Long COVID Treatments: Reuters ↗

March 25, 2022

Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 16, 2022

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 114.0% to $0.59 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 11, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) shares increased by 35.2% to $1.82 during Friday's regular session. Clearside Biomedical's stock is trading at a volume...

Via Benzinga

Insiders Buying These 4 Penny Stocks ↗

March 07, 2022

US crude oil futures surged to their strongest levels since 2008 early this morning, amid the risk of Western ban on Russia’s oil imports. Investors, meanwhile, focused on some notable insider trades

Via Benzinga

Humanigen's Return On Capital Employed Insights ↗

March 03, 2022

According to Benzinga Pro data, during Q4, Humanigen (NASDAQ:HGEN) posted sales of $1.04 million. Earnings were up 49.74%, but Humanigen still reported an overall loss of $33.54...

Via Benzinga

44 Stocks Moving In Tuesday's Mid-Day Session ↗

March 01, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on...

Via Benzinga

50 Stocks Moving In Friday's Mid-Day Session ↗

March 11, 2022

Gainers Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) shares rose 63.5% to $1.13....

Via Benzinga

Humanigen to Present and Participate at Multiple Investor Events in March

February 25, 2022

From Humanigen, Inc.

Via Business Wire

80 Biggest Movers From Yesterday ↗

March 02, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...

Via Benzinga

25 Stocks Moving in Monday's Pre-Market Session ↗

February 14, 2022

Gainers Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 52.8% to $0.65 in pre-market trading after declining 6% on Friday. TC BioPharm (Holdings) plc (NASDAQ: TCBP)...

Via Benzinga

52 Weeks High And Low Article ↗

February 11, 2022

On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company...

Via Benzinga

Humanigen to Present at BIO CEO & Investor Conference

February 11, 2022

From Humanigen, Inc.

Via Business Wire

Humanigen Launches Managed Access Program for Lenzilumab

February 09, 2022

From Humanigen, Inc.

Via Business Wire

Humanigen, Cenexi Ink Manufacture Pact For COVID-19 Candidate, Lenzilumab, In France ↗

February 09, 2022

Humanigen Inc (NASDAQ: HGEN) has selected Cenexi as a preferred supplier of lenzilumab in France and the European Union.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.